top of page

PUBLICATIONS

"If you know you are on the right track, if you have this inner knowledge, then nobody can turn you off... no matter what they say."

- Barbara McClintock

 

  1. K.A. Greco, C.A. Franzen, K.E. Foreman, R.C. Flanigan, P.C. Kuo, G.N. Gupta. PLK-1 Silencing in Bladder Cancer by siRNA Delivered with Exosomes. Urology. Urology 2016 May: 91(241), e 1-7.

  2. C.A. Franzen, R. H. Blackwell, K.E. Foreman, P.C. Kuo, G.N. Gupta. Urinary Exosomes: The Potential for Biomarker Utility, Intercellular Signaling, and Therapeutics in Urologic Malignancy. Invited Review for Journal of Urology 2016 May; 195(5): 1331-9. 

  3. C.A. Franzen, R.H. Blackwell, V. Todorovic, K.A. Greco, K. E. Foreman, R.C. Flanigan, P.C. Kuo, and G.N. Gupta. Urothelial Cells Undergo Epithelial to Mesenchymal Transition After Exposure to Muscle Invasive Bladder Cancer Exosomes. Oncogenesis 2015 Aug 17.

  4. J. Driver, C.E. Weber, J.J. Callaci, A. Kothari, M.A. Zapf, P.K. Roper, D. Borys, C.A. Franzen, G.N. Gupta, P.Y. Wai, J. Zhang, P.C. Kuo, Z. Mi. Alcohol Inhibits Osteopontin Dependent Transforming Growth Factor-β1 Expression in Human Mesenchymal Stem Cells. Journal of Biological Chemistry 2015 Apr 17; 290(16).

  5. R.H. Blackwell, C.A. Franzen, R.C. Flanigan, P.C. Kuo and G.N. Gupta. The untapped potential of urine shed bladder cancer exosomes: biomarkers, signaling, and therapeutics. Bladder 2014; 1(1)

  6. Z. Mi , C.Weber, P. Wai, N. Li, J. Driver, C.A. Franzen, G.N. Gupta, J. Zhang, and P.C. Kuo. Osteopontin Mediates TGF-β1 Dependent Transformation Of Mesenchymal Stem Cells Into Cancer Associated Fibroblasts In Breast Cancer Oncogene 2014 Dec 22

  7. C.E. Weber, J. Driver, C.A. Franzen, J.B. Mascarenhas, Z. Mi, G.N. Gupta, P.Y. Wai, and P.C. Kuo. The Constituents and Potential Targets of the Extracellular Matrix: Implications for Carcinogenesis and Cancer Treatment. Carcinogenesis and Mutagenesis 2013.

  8. C.A. Franzen, P.E. Simms, A.F. Van Huis, K.E. Foreman, P.C. Kuo, and G.N. Gupta. Characterization of Uptake and Internalization of Exosomes by Bladder Cancer Cells. BioMed Research International 2014.

  9. S. Mirzoeva, C. A. Franzen, and J. C. Pelling.  Apigenin inhibits VEGF expression in human prostate carcinoma cells via a Smad- and Src-dependent mechanism. Molecular Carcinogenesis 2013.

  10. C.A. Franzen, V. Todorović, B.V. Desai, K.J. Green, and J.C. Pelling. The desmosomal armadillo protein plakoglogin regulates prostate cancer cell adhesion and motility through vitronectin-dependent Src signaling PLoS One 2012 July; 7(7)

  11. C.A. Franzen, E. Amargo, V. Todorovic, B.V. Desai, S. Huda, S. Mirzoeva, K. Chiu, B.A. Grzybowski, T-L Chew, K.J. Green, and J.C. Pelling. The chemopreventive bioflavonoid apigenin inhibits PC3-M cell motility through the focal adhesion kinase (FAK)/Src signaling pathway. Cancer Prev Res. 2009 Sep;2(9):830-41.

  12. Mirzoeva S., N.D. Kim, K. Chiu, C.A. Franzen, R.C. Bergan, and J.C. Pelling. Inhibition of HIF-1 alpha and VEGF Expression by the Chemopreventive Bioflavonoid Apigenin is Accompanied by Akt Inhibition in Human Prostate Carcinoma PC3-M Cells. Mol Carcinog. 2008 Sep;47(9):686-700.

  13. Franzen, C.A., C.C. Chen, V. Todorović, V. Jurić, R.I. Monzon, and L.F. Lau. Integrin-Mediated Matrix Signaling Regulates TRAIL-Induced Apoptosis in Prostate Carcinoma Cells. Mol. Cancer Res. 2009 Jul; 7(7):1045-55

 

Publications
Abstracts

  1. W. Wang, C.A. Franzen, M. Sukhanova, G. Venkataraman, M. Ming, A. Guo, P. Lu, D. Sheng, A. Gao, C. Xia, J. Li, X. Zhou, and Y. L. Wang. RAC2 mediates the link between B-Cell Receptor signaling and cell adhesion in mantle cell lymphoma. Lymphoma Research Foundation Mantle Cell Lymphoma Workshop, Atlanta, 2018, Oral Presentation.

  2. W. Wang, C.A. Franzen, M. Sukhanova, G. Venkataraman, M. Ming, A. Guo, P. Lu, D. Sheng, A. Gao, C. Xia, J. Li, X. Zhou, and Y. L. Wang. RAC2 links B-cell receptor signaling and cell adhesion in mantle cell lymphoma. American Society for Hematology, Atlanta, 2017, Poster.

  3. C.A. Franzen, K.A. Greco, R.H. Blackwell, K.E. Foreman, G.N. Gupta. Urothelial cells undergo epithelial to mesenchymal transition after exposure to muscle invasive bladder cancer exosomes. American Urological Association annual meeting, New Orleans, 2015, Poster.

  4. A.F. Van Huis, C.A. Franzen, and G.N. Gupta. Exosome-Mediated Regulation of PTEN Expression in Bladder Cancer. American Urological Association annual meeting, Orlando, 2014, Poster.

  5. K.A. Greco, C.A. Franzen, P.C. Kuo, R.C. Flanigan, and G.N. Gupta. PLK1 Silencing in Bladder Cancer by siRNA Delivered with Exosomes. American Urological Association annual meeting, Orlando, 2014, Poster.

  6. C.A. Franzen, P. Simms, K.E. Foreman, and G.N. Gupta. Novel Method Of Exosome Quantification And Cellular Uptake Using The Amnis ImageStreamX. International Society for Extracellular Vesicles meeting, Boston, 2013, Poster.

  7. C.A. Franzen, V. Todorović, J.C. Pelling, R.C. Bergan. Apigenin regulates prostate cancer matrix composition, cell attachment, and cell motility through an integrin alpha 1 dependent pathway. Aspen Cancer Conference, Aspen, 2012, Poster.

  8. C.A. Franzen, V. Todorović, J.C. Pelling, R.C. Bergan. Apigenin regulates prostate cancer matrix composition, cell attachment, and cell motility through an integrin alpha 1 dependent pathway. American Association for Cancer Research, Chicago, 2012, Poster.

  9. C.A. Franzen, S. Mirzoeva, R.C. Bergan, K.J. Green, and J.C. Pelling. Apigenin inhibits PC3-M cell motility through the FAK/Src signaling pathway. Cytoskeleton Signaling in Cancer meeting, San Diego, 2008, Poster.

  10. C.A. Franzen, R.I. Monzon, and L.F. Lau. The extracellular matrix protein CCN1 (CYR61) sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. American Association for Cancer Research, Washington D.C., 2006, Poster.

 

 

 

 

 

 

 

 

 

 

bottom of page